Forsta AP Fonden Sells 6,220 Shares of Intuitive Surgical, Inc. $ISRG

Forsta AP Fonden trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 85,680 shares of the medical equipment provider’s stock after selling 6,220 shares during the period. Forsta AP Fonden’s holdings in Intuitive Surgical were worth $48,526,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Newbridge Financial Services Group Inc. grew its holdings in Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 33 shares in the last quarter. Holos Integrated Wealth LLC bought a new position in Intuitive Surgical during the 4th quarter worth about $25,000. Olistico Wealth LLC bought a new position in Intuitive Surgical during the 4th quarter worth about $28,000. Laurel Wealth Advisors LLC bought a new position in Intuitive Surgical during the 4th quarter worth about $31,000. Finally, Turning Point Benefit Group Inc. grew its holdings in Intuitive Surgical by 833.3% during the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after acquiring an additional 50 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have issued reports on ISRG shares. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Sunday, May 24th. JPMorgan Chase & Co. dropped their target price on shares of Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Piper Sandler lowered their price target on shares of Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Jefferies Financial Group lowered their price target on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a report on Wednesday, April 22nd. Finally, Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target on the stock in a report on Wednesday, March 11th. Nineteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $576.71.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $424.59 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $414.30 and a fifty-two week high of $603.88. The stock has a market capitalization of $150.37 billion, a P/E ratio of 51.47, a P/E/G ratio of 3.38 and a beta of 1.51. The company’s 50-day simple moving average is $453.54 and its 200-day simple moving average is $506.43.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. During the same period last year, the business earned $1.81 EPS. The company’s revenue was up 23.0% compared to the same quarter last year. On average, research analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street optimism is supporting the stock, with one article arguing Intuitive Surgical could rise more than 30% from current levels because analysts believe the long-term growth story remains intact and the recent selloff has created an attractive entry point. Article Title
• Positive Sentiment: Intuitive Surgical announced a leadership change in commercial and marketing, promoting Taylor Patton to Chief Commercial and Marketing Officer effective July 1, which may be viewed as a continuity move that could support execution and sales strategy. Article Title
• Neutral Sentiment: Market commentary noted the stock is still trading well below its recent high, underscoring that investor caution remains elevated even though the company continues to be viewed as a leader in robotic-assisted surgery. Article Title
• Neutral Sentiment: Third-party market reports described ISRG as underperforming peers and highlighted recent short-interest data, but the figures did not show a clear new bearish catalyst. Article Title
• Neutral Sentiment: Intuitive Surgical also appeared in broader “physical AI” and robotics commentary, which is more of a thematic mention than a company-specific catalyst for the stock. Article Title

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 105 shares of the stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Amy L. Ladd sold 500 shares of the stock in a transaction that occurred on Tuesday, April 28th. The shares were sold at an average price of $473.46, for a total transaction of $236,730.00. Following the completion of the transaction, the director directly owned 239 shares of the company’s stock, valued at $113,156.94. The trade was a 67.66% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 5,481 shares of company stock valued at $2,673,871. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.